Operating

Accretion (Amortization) of Discounts and Premiums, Investments

Analysis

StatementCash Flow Statement
SectionOperating
CategoryOther
SignalContext dependent
VolatilityStable
First reportedQ1 2025
Last reportedQ1 2026May 26, 2026

How to read this metric

Fluctuations reflect changes in the yield and maturity profile of the company's investment portfolio.

Detailed definition

This represents the non-cash adjustment to the carrying value of investment securities held by the company. It reflects...

Peer comparison

Standard for companies with significant treasury or client fund investment portfolios.

Metric ID: operating_accretion_amortization_of_discounts_and_premiu_124409

Historical Data

2 periods
 Q1 '25Q1 '26
Value$0.00$1.23M
Range$0.00$1.23M

Frequently Asked Questions

What is Kailera Therapeutics 's accretion (amortization) of discounts and premiums, investments?
Kailera Therapeutics (KLRA) reported accretion (amortization) of discounts and premiums, investments of $1.23M in Q1 2026.
What does accretion (amortization) of discounts and premiums, investments mean?
The non-cash adjustment to the value of investment holdings over time.